NCT05575466

Brief Summary

BACKGROUND: Sudden death due to thromboembolic (TE) events in patients with anorexia nervosa (AN) is well known. However, the incidence of TE events and the hemostatic balance in patients with AN are sparsely investigated. Also, associations between re-nutrition and the hemostatic balance have not been studied. OBJECTIVE: To describe the incidence of TE events in patients with AN compared to the background population, to characterize the hemostatic balance in AN compared to normal-weight women, and to assess the associations between the hemostatic balance and nutritional status, insulin sensitivity and cortisol level in women with AN. METHODS: The incidence of TE will be described using a Danish cohort of AN patients (n=10,049) with follow-up in national registries. A comprehensive battery of hemostatic biomarkers will be compared in a case-control study of 40 patients with AN and associations between hemostasis and nutritional status will be studied.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2022

Geographic Reach
2 countries

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 5, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 12, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

November 15, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2024

Completed
Last Updated

October 15, 2024

Status Verified

October 1, 2024

Enrollment Period

1.9 years

First QC Date

October 5, 2022

Last Update Submit

October 10, 2024

Conditions

Keywords

Anorexia NervosaThrombosisThromboembolismCortisolInsulinNutritionRefeeding Syndrome

Outcome Measures

Primary Outcomes (1)

  • Incidence of thromboembolic events

    Arterial and venous thrombosis. Non-fatal outcomes of a thromboembolic event will be validated by the use of anticoagulants in the period immediately after the outcome defining event.

    Data on thromboembolic events are collected from health registries. Data is collected through study completion of the time frame in the registry, up to 26 years.

Other Outcomes (2)

  • Hemostatic balance

    The study is cross-sectional. Time frame for completion of participation in the study is 1 day.

  • Rotational Thromboelastometry (ROTEM)-variables

    The study is cross-sectional. Time frame for completion of participation in the study is 1 day.

Study Arms (2)

Patients

Will have thromboembolic incidence rate evaluated and will have a battery of hemostatic markers analyzed

Diagnostic Test: Blood samplesDiagnostic Test: Questionnaires

Controls

Will have thromboembolic incidence rate evaluated and will have a battery of hemostatic markers analyzed

Diagnostic Test: Blood samples

Interventions

Blood samplesDIAGNOSTIC_TEST

Hemostatic biomarkers

ControlsPatients
QuestionnairesDIAGNOSTIC_TEST

Eating Disorder Inventory - third version (EDI-3) Eating Disorder Quality of Life Scale (EDQLS)

Patients

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients with anorexia nervosa and healthy, age-matched controls.

You may qualify if:

  • Fulfilling Diagnostic and Statistical Manual V (DSM-5) criteria for AN
  • Age 18 - 50 years
  • Female sex

You may not qualify if:

  • Somatic comorbidity requiring systemic medications
  • Previous thromboembolic event and/or known genetic predisposition
  • Use of p.o. hormonal contraception
  • Smoking
  • BMI 18.5 - 25.0
  • Age 18 - 50 years
  • Female sex
  • Somatic comorbidity requiring systemic medications
  • Previous thromboembolic event and/or known genetic predisposition
  • Use of p.o. hormonal contraception
  • Smoking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Clinical Pharmacology and Pharmacy, University of Southern Denmark

Odense, Fyn, 5000, Denmark

Location

Department of Child and Adolescent Mental Health Odense, Mental Health Services in the Region of Southern Denmark

Odense, Fyn, 5000, Denmark

Location

The Nutritional Unit, Department of Endocrinology, Center for Eating Disorders, Odense University Hospital and Psychiatry in the region of Southern Denmark

Odense, Fyn, 5220, Denmark

Location

Unit for Thrombosis Research, Department of Clinical Biochemistry, Hospital of South West Jutland

Esbjerg, Jylland, 6700, Denmark

Location

Department of Clinical Sciences, Umeå University

Umeå, Västerbotten County, Sweden

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood samples

MeSH Terms

Conditions

Anorexia NervosaThrombosisThromboembolismInsulin ResistanceRefeeding Syndrome

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental DisordersEmbolism and ThrombosisVascular DiseasesCardiovascular DiseasesHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesMalnutritionNutrition Disorders

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

October 5, 2022

First Posted

October 12, 2022

Study Start

November 15, 2022

Primary Completion

October 10, 2024

Study Completion

October 10, 2024

Last Updated

October 15, 2024

Record last verified: 2024-10

Locations